therefore, a family or personal history of MTC or MEN2 is a contraindication for GLP-1class agents in many labels
86 PicconiB.PisaniA.BaroneI.BonsiP.CentonzeD.BernardiG.et al (2005)
Gastrointestinal symptoms: Mild nausea is common during the first week at each new dose
Studies: Fat metabolism and weight management: A study in Obesity Reviews showed that L-Carnitine supplementation resulted in greater reductions in body weight and BMI, particularly in overweight and obese populations, though it was most effective when combined with exercise
Recommended rotation strategy: Rotate between the three approved sites : abdomen, thighs, and upper arms Within each site, move the injection location by at least 2.5 cm (1 inch) from the previous injection Establish a systematic pattern for example, abdomen for week one, right thigh for week two, left thigh for week three, right arm for week four, then repeat Keep a written record or use a smartphone app to track injection sites and dates Avoid injecting within 5 cm (2 inches) of the navel, scars, moles, or the waistline Absorption considerations: Product information for GLP-1 medications indicates no clinically relevant differences in absorption between approved injection sites
If you retry copper peptides, go low and slow, patch test, and avoid stacking with vitamin C or strong exfoliants
